Browsing Category
Healthcare Industry News
2469 posts
Hims & Hers targets preventive diagnostics with YourBio Health acquisition for pain-free blood sampling
Discover how Hims & Hers is reshaping preventive care by acquiring YourBio Health and bringing pain-free blood sampling into home-based diagnostics.
What Erik Todd’s appointment reveals about Swan EndoSurgical’s strategy for advanced GI robotics
Swan EndoSurgical appoints former Stryker executive Erik Todd as CEO to accelerate flexible surgical robotics. See how this move reshapes GI intervention strategy.
What Mitchell Rock’s appointment as CEO could mean for UFP Technologies’ strategy
UFP Technologies appoints President Mitchell Rock as CEO from June 2026, ending R. Jeffrey Bailly’s 31-year tenure. Find out what this leadership shift means.
UnitedHealth’s $1bn Banmédica divestment marks strategy shift under Hemsley
UnitedHealth agrees to sell Banmédica to Patria for $1 billion, marking its full exit from Latin America. Find out what this strategic shift means.
What makes SimonMed’s partnership with Lunit a turning point in clinical imaging?
SimonMed Imaging partners with Lunit to launch scalable, fine-tuned AI for chest X-ray reporting. Explore how this foundation model could change radiology forever.
Why Paragon Care (ASX:PGC) is doubling down on Asia’s aesthetics and medtech markets
Paragon Care is betting on A$98 million in Asian acquisitions to reignite earnings. Can this strategy reverse a 41% stock slump? Read the full story.
Can Celltrion’s Eydenzelt disrupt Canada’s aflibercept market after Health Canada approval?
Celltrion secures Health Canada approval for Eydenzelt, its aflibercept biosimilar. Explore how it aims to disrupt Canada’s high-cost eye care drug market.
Can Moolec avoid delisting? Nasdaq hearing set for December 18
Moolec faces a critical Nasdaq compliance hearing over its delayed 20-F report. Explore what this means for MLEC investors and the future of molecular farming.
INVO Fertility eyes major Midwest expansion through Family Beginnings fertility clinic acquisition
Discover how INVO Fertility’s planned acquisition of Family Beginnings could reshape Midwest fertility care and accelerate its national clinic expansion strategy.
Why HeartBeam’s 510(k) appeal could reshape cardiac software approval timelines
HeartBeam outlines a dual-track regulatory strategy after FDA setback on ECG software. See how it plans to unlock clearance and stay on track for market entry.